SIRT1 and the clock gene machinery in colorectal cancer

Cancer Investigation

Volumn 30, Issue 2, 2012, Pages 98-105

  Pazienza, Valerio ^a   Piepoli, Ada ^a   Panza, Anna ^a   Valvano, Maria Rosa ^a   Benegiamo, Giorgia ^a   Vinciguerra, Manlio ^b,c   Andriulli, Angelo ^a   Mazzoccoli, Gianluigi ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b Istituto EuroMediterraneo di Scienza e Tecnologia   (Italy)

^c UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Clock genes; Colorectal cancer; SIRT1

Indexed keywords

CELL PROTEIN; CRYPTOCHROME 1; PER1 PROTEIN; PER2 PROTEIN; PER3 PROTEIN; PROTEIN ARNTL1; PROTEIN CSNKIE; PROTEIN TIPIN; SIRTUIN 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CLOCK; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CELL STRAIN CACO 2; CLINICAL ARTICLE; CLOCK GENE; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOLECULAR CLOCK; PRIORITY JOURNAL; SIRT1 GENE;

AGED; AGED, 80 AND OVER; CACO-2 CELLS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CLOCK PROTEINS; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; SIRTUIN 1; TRANSFECTION;

EID: 84856102521     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2011.640650     Document Type: Article

References (53)

1. Guarente, L, Franklin H. Epstein lecture: sirtuins, aging, and medicine. N Engl J Med 2011;364:2235-2244.
2. Brooks CL, GuW.How does SIRT1 affect metabolism, senescence and cancer? Nat Rev Cancer 2009;9:123-128.
3. Zhao W, Kruse JP, Tang Y, Jung SY, Qin J, Gu W. Negative regulation of the deacetylase SIRT1 by DBC1. Nature 2008;451: 587-590. (Pubitemid 351186268)
4. Edery I. Circadian rhythms in a nutshell. Physiol Genomics 2000;3:59-74.
5. Lowrey PL, Takahashi JS. Genetics of the mammalian circadian system: photic entrainment, circadian pacemaker mechanisms, and posttranslational regulation. Annu Rev Genet 2000;34:533-562. (Pubitemid 32065932)
6. Nagoshi E, Saini C, Bauer C, Laroche T, Naef F, Schibler U. Circadian gene expression in individual fibroblasts: Cell-autonomous and self-sustained oscillators pass time to daughter cells. Cell 2004;119:693-705. (Pubitemid 39535756)
7. Filipski E, King VM, EtienneMC, Li XM, Claustrat B, Granda TG. Persistent twenty-four hour changes in liver and bonemarrowdespite suprachiasmatic nuclei ablation in mice. Am J Physiol Regul Integr Comp Physiol 2004;287:R844-R851. (Pubitemid 39280471)
8. Eide EJ, Vielhaber EL, HinzWA, Virshup DM.The circadian regulatory proteins BMAL1 and cryptochromes are substrates of casein kinase Ie. J Biol Chem 2002;277:17248-17254. (Pubitemid 34967759)
9. Smith KD, Fu MA, Brown EJ. Tim-Tipin dysfunction creates an indispensible reliance on the ATR-Chk1 pathway for continued DNA synthesis. J Cell Biol 2009;5:15-23.
10. Yang X, Wood PA, Hrushesky WJ. Mammalian TIMELESS is required for ATM-dependent CHK2 activation and G2/M checkpoint control. J Biol Chem 2010;285:3030-3034.
11. Kemp MG, Akan Z, Yilmaz S, Grillo M, Smith-Roe SL, Kang TH, Cordeiro-Stone M, Kaufmann WK, Abraham RT, Sancar A, Unsal-Kacmaz K. Tipin-replication protein A interaction mediates Chk1 phosphorylation by ATR in response to genotoxic stress. J Biol Chem 2010;285:16562-16571.
12. Unsal-Kacmaz K, Chastain PD, Qu PP, Minoo P, Cordeiro-Stone M, Sancar A, Kaufmann WK.The human Tim/Tipin complex coordinates an Intra-S checkpoint response to UV that slows replication fork displacement. Mol Cell Biol 2007;27:3131-3142. (Pubitemid 46581324)
13. Asher G, Gatfield D, Stratmann M, Reinke H, Dibner C, Kreppel F, Mostoslavsky R, Alt FW, Schibler U. SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell 2008;134:317-328. (Pubitemid 352024391)
14. Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H. Control mechanism of the circadian clock for timing of cell division in vivo. Science 2003;302:255-259. (Pubitemid 37248750)
15. Filipski E, King VM, Li XM, Granda TG, Mormont MC, Liu X. Host circadian clock as a control point in tumor progression. J Natl Cancer Inst 2002;94:690-697. (Pubitemid 34552490)
16. Hunt T, Sassone-Corsi P. Riding tandem: Circadian clocks and the cell cycle. Cell 2007;129:461-464. (Pubitemid 46660976)
17. Wille JJ Jr. Circadian rhythm of tumor promotion in the twostage model of mouse tumorigenesis. Cancer Lett 2003;190: 143-149. (Pubitemid 36136012)
18. Kondratov RV, Antoch MP. Circadian proteins in the regulation of cell cycle and genotoxic stress responses. Trends Cell Biol 2007;17:311-317. (Pubitemid 47102196)
19. Fang Y, Nicholl MB. Sirtuin 1 in malignant transformation: friend or foe? Cancer Lett 2011;306:10-14.
20. Akao Y, Noguchi S, Iio A, Kojima K, Takagi T, Naoe T. Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells. Cancer Lett 2011;300:197-204.
21. Chua KF, Mostoslavsky R, Lombard DB, Pang WW, Saito S, Franco S, Kaushal D, Cheng HL, Fischer MR, Stokes N, Murphy MM, Appella E, Alt FW. Mammalian SIRT1 limits replicative life span in response to chronic genotoxic stress. Cell Metab 2005;2:67-76. (Pubitemid 43239826)
22. Heltweg B, Gatbonton T, Schuler AD, Posakony J, Li H, Goehle S, Kollipara R, DepinhoRA, Gu Y, Simon JA, BedalovA.Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes. Cancer Res 2006;66:4368-4377.
23. Ota H, Tokunaga E, Chang K, Hikasa M, Iijima K, Eto M, Kozaki K, Akishita M, Ouchi Y, Kaneki M. Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras- MAPK signaling in human cancer cells. Oncogene 2006;25:176-185. (Pubitemid 43083679)
24. Wang C, Chen L,Hou X, Li Z, Kabra N,Ma Y, Nemoto S, Finkel T, Gu W, Cress WD, Chen J. Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage. Nat Cell Biol 2006;8:1025-1031. (Pubitemid 44314735)
25. Pruitt K, Zinn RL, Ohm JE, McGarvey KM, Kang SH, Watkins DN, Herman JG, Baylin SB. Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation. PLoS Genet 2006;2:e40.
26. Chan DS, Lau R, Aune D, Vieira R, Greenwood DC, Kampman E, Norat T. Red and processedmeat and colorectal cancer incidence: meta-analysis of prospective studies. PLoS One 2011;6:e20456.
27. Nakama H, Zhang B, Fukazawa K. Colorectal cancer screening under the age of 50 is less cost-effective. Cancer Invest 2002;20:290-291. (Pubitemid 34205495)
28. Livak KJ, Schmittgen TD.Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-408. (Pubitemid 34164012)
29. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, Hu LS, Cheng HL, Jedrychowski MP, Gygi SP, Sinclair DA, Alt FW, Greenberg ME. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004;303:2011-2015. (Pubitemid 38393275)
30. Kabra N, Li Z, Chen L, Li B, Zhang X,Wang C, Yeatman T, Coppola D, Chen J. SirT1 is an inhibitor of proliferation and tumor formation in colon cancer. J Biol Chem 2009;284:18210-18217.
31. Roncoroni L, Elli L, Bardella MT, Dogliotti E, Grimoldi MG, Viaggi S, Erba E, Zunino A, Doneda L. Cytogenetic characterization and cell cycle analysis of three human colon adenocarcinoma cell lines: Comparison between two- and three-dimensional cell culture systems. Cancer Invest 2010;28:7-12.
32. Shan BE, Wang MX, Li RQ. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway. Cancer Invest 2009;27:604-612.
33. Li M, Xie J, Cheng L, Chang B, Wang Y, Lan X, Zhang D, Yin Y, Cheng N. Suppression of invasive properties of colorectal carcinoma SW480 cells by 15-hydroxyprostaglandin dehydrogenase gene. Cancer Invest 2008;26:905-912.
34. Fu L, Pelicano H, Liu J, Huang P, Lee CC. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 2002;111:41-50.
35. Yang X, Wood PA, Ansell CM, Quiton DF, Oh EY, Du-Quiton J, Hrushesky WJ. The circadian clock gene Per1 suppresses cancer cell proliferation and tumor growth at specific times of day. Chronobiol Int 2009;26:1323-1339.
36. Wood PA, Yang X, Taber A, Oh EY, Ansell C, Ayers SE, Al-Assaad Z, Carnevale K, Berger FG, Pẽna MM, Hrushesky WJ. Period 2 mutation accelerates ApcMin/+tumorigenesis. Mol Cancer Res 2008;6:1786-1793.
37. Im JS, Jung BH, Kim SE, Lee KH, Lee JK. Per3, a circadian gene, is required for Chk2 activation in human cells. FEBS Lett 2010;584:4731-4734.
38. Krugluger W, Brandstaetter A, Ḱallay E, Schueller J, Krexner E, Kriwanek S, Bonner E, Cross HS. Regulation of genes of the circadian clock in human colon cancer: Reduced period-1 and dihydropyrimidine dehydrogenase transcription correlates in highgrade tumors. Cancer Res 2007;67:7917-7922. (Pubitemid 47281388)
39. Yang X, Wood PA, Ansell C, Hrushesky WJ. Circadian timedependent tumor suppressor function of period genes. Integr Cancer Ther 2009;8:309-316.
40. Jung-Hynes B, Ahmad N. SIRT1 controls circadian clock circuitry and promotes cell survival: A connection with age-related neoplasms. FASEB J 2009;23:2803-2809.
41. Kojima K, Ohhashi R, Fujita Y, Hamada N, Akao Y, Nozawa Y, Deguchi T, Ito M. A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells. Biochem Biophys Res Commun 2008;373:423-428.
42. Brooks CL, GuW.How does SIRT1 affect metabolism, senescence and cancer? Nat Rev Cancer 2009;9:123-128.
43. Yamakuchi M, Lowenstein CJ. MiR-34, SIRT1 and p53: The feedback loop. Cell Cycle 2009;8:712-715.
44. Liu X, Wang D, Zhao Y, Tu B, Zheng Z, Wang L, Wang H, Gu W, Roeder RG, Zhu WG. Methyltransferase Set7/9 regulates p53 activity by interacting with Sirtuin 1 (SIRT1). Proc Natl Acad Sci USA 2011;108:1925-1930.
45. Yamakuchi M, Ferlito M, Lowenstein CJ. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci USA 2008;105:13421-13426.
46. Yi J, Luo J. SIRT1 and p53, effect on cancer, senescence and beyond. Biochim Biophys Acta 2010;1804:1684-1689.
47. Fu L, Lee CC. The circadian clock: pacemaker and tumour suppressor. Nature Rev Cancer 2003;3:350-361. (Pubitemid 37328855)
48. Chen-Goodspeed M, Lee CC. Tumor suppression and circadian function. J Biol Rhythms 2007;22:291-298.
49. LeeCC. Tumor suppression by themammalian Period genes.Cancer Causes Control 2006;17:525-530.
50. Wood PA, Yang X, Hrushesky WJ. Clock genes and cancer. Integr Cancer Ther 2009;8:303-308.
51. Hrushesky WJ, Grutsch J, Wood PA, Yang X, Oh EY, Ansell C, Kidder S, FerransC,QuitonDF, Reynolds J, Du-QuitonJ,LevinR, Lis C, Braun D. Circadian clock manipulation for cancer prevention and control and the relief of cancer symptoms. Integr Cancer Ther 2009;8:387-397.
52. Firestein R, Blander G,Michan S, Oberdoerffer P,Ogino S, Campbell J, Bhimavarapu A, Luikenhuis S, de Cabo R, Fuchs C, Hahn WC, Guarente LP, Sinclair DA.The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS One 2008;3:e2020.
53. Buck E, Eyzaguirre A, Barr S, Thompson S, Sennello R, Young D, Iwata KK, Gibson NW, Cagnoni P, Haley JD. Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition. Mol Cancer Ther 2007;6:532-541. (Pubitemid 46332455)